MDT perspectives on minimizing TKI-associated toxicities in patients with CML

09/05/2022 13 min Episodio 120
MDT perspectives on minimizing TKI-associated toxicities in patients with CML

Listen "MDT perspectives on minimizing TKI-associated toxicities in patients with CML"

Episode Synopsis

touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team explore how to minimize toxicities while maximizing treatment benefit for patients with chronic myeloid leukaemia
The multidisciplinary team 
Nurse specialist: Johan De Munter, Belgium
Haematologist: Prof. Dr med. Andreas Hochhaus, Germany

This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/
 

More episodes of the podcast touchPODCAST